What is the prognosis for patients taking Temozolomide?
The prognosis for patients taking temozolomide varies widely based on the type and stage of cancer, as well as individual patient factors. For glioblastoma patients, the addition of temozolomide to the treatment regimen has been shown to extend median survival times and improve overall survival rates. However, glioblastoma remains a highly aggressive cancer with a generally poor prognosis. Ongoing research aims to improve outcomes through combination therapies and novel treatment approaches.
